BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25557123)

  • 1. Is cognitive impairment in cirrhotic patients due to increased peroxynitrite and oxidative stress?
    Gimenez-Garzó C; Urios A; Agustí A; González-López O; Escudero-García D; Escudero-Sanchis A; Serra MA; Giner-Durán R; Montoliu C; Felipo V
    Antioxid Redox Signal; 2015 Apr; 22(10):871-7. PubMed ID: 25557123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment.
    Giménez-Garzó C; Urios A; Agustí A; Mangas-Losada A; García-García R; Escudero-García D; Kosenko E; Ordoño JF; Tosca J; Giner-Durán R; Serra MA; Felipo V; Montoliu C
    Free Radic Res; 2018 Jan; 52(1):118-133. PubMed ID: 29262736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
    Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
    Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy.
    García-García R; Cruz-Gómez ÁJ; Mangas-Losada A; Urios A; Forn C; Escudero-García D; Kosenko E; Ordoño JF; Tosca J; Giner-Durán R; Serra MA; Avila C; Belloch V; Felipo V; Montoliu C
    PLoS One; 2017; 12(10):e0186463. PubMed ID: 29023586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
    J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests.
    Felipo V; Ordoño JF; Urios A; El Mlili N; Giménez-Garzó C; Aguado C; González-Lopez O; Giner-Duran R; Serra MA; Wassel A; Rodrigo JM; Salazar J; Montoliu C
    Hepatology; 2012 Feb; 55(2):530-9. PubMed ID: 21953369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications.
    Cabrera-Pastor A; Llansola M; Montoliu C; Malaguarnera M; Balzano T; Taoro-Gonzalez L; García-García R; Mangas-Losada A; Izquierdo-Altarejos P; Arenas YM; Leone P; Felipo V
    Acta Physiol (Oxf); 2019 Jun; 226(2):e13270. PubMed ID: 30830722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy.
    Felipo V; Urios A; Montesinos E; Molina I; Garcia-Torres ML; Civera M; Olmo JA; Ortega J; Martinez-Valls J; Serra MA; Cassinello N; Wassel A; Jordá E; Montoliu C
    Metab Brain Dis; 2012 Mar; 27(1):51-8. PubMed ID: 22072427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in minimal hepatic encephalopathy.
    Badea MA; Prelipcean CC; Mihai C; Drug V
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):9-17. PubMed ID: 25970936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of oxidative stress in aging NZB/NZW mice: effect of fish oil feeding on hepatic antioxidant status and guanidino compounds.
    Kim YJ; Yokozawa T; Chung HY
    Free Radic Res; 2005 Oct; 39(10):1101-10. PubMed ID: 16298735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients.
    Rubio T; Felipo V; Tarazona S; Pastorelli R; Escudero-García D; Tosca J; Urios A; Conesa A; Montoliu C
    Sci Rep; 2021 Jan; 11(1):1907. PubMed ID: 33479266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
    Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
    J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased oxidative stress and altered levels of nitric oxide and peroxynitrite in Tunisian patients with chronic obstructive pulmonary disease: correlation with disease severity and airflow obstruction.
    ben Anes A; Fetoui H; Bchir S; ben Nasr H; Chahdoura H; Chabchoub E; Yacoub S; Garrouch A; Benzarti M; Tabka Z; Chahed K
    Biol Trace Elem Res; 2014 Oct; 161(1):20-31. PubMed ID: 25074430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy.
    San Martín-Valenzuela C; Borras-Barrachina A; Gallego JJ; Urios A; Mestre-Salvador V; Correa-Ghisays P; Ballester MP; Escudero-García D; Tosca J; Montón C; Ríos MP; Kosenko E; Felipo V; Tabares-Seisdedos R; Selva-Vera G; Montoliu C
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32650464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal hepatic encephalopathy impairs fitness to drive.
    Wein C; Koch H; Popp B; Oehler G; Schauder P
    Hepatology; 2004 Mar; 39(3):739-45. PubMed ID: 14999692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.